CELT ACD VASCULAR CLOSURE DEVICE

Device, Hemostasis, Vascular

FDA Premarket Approval P150006

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the celt acd vascular closure device. This device is indicated for the percutaneous closure of common femoral artery puncture sites while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional intra-arterial catheterization procedures where either 5f or 6f introducer sheaths have been used.

DeviceCELT ACD VASCULAR CLOSURE DEVICE
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantVASORUM LTD
Date Received2015-02-03
Decision Date2016-07-20
Notice Date2016-07-25
PMAP150006
SupplementS
Product CodeMGB
Docket Number16m-2185
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address VASORUM LTD 2012 Orchard Ave citywest Business Campus dublin 24
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150006Original Filing
S004 2019-08-13 30-day Notice
S003
S002
S001 2016-10-17 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
05391530280150 P150006 001
05391530280129 P150006 001
05391530280099 P150006 001
05391530280068 P150006 001
05391530280037 P150006 001
05391530280006 P150006 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.